Molecular Genetics & Therapy - 2Genetic polymorphismsPharmacogenomics in cancer drug discovery and developmentTherapeutic windows in the genetic engineering of hematopoietic cellsMutations of TP53 in cancers of the head and neck and of the oesophagus: implications for the identification of environmental factors of risk. |
Site Contents
|